MKManish Kolakshyapati

Manish Kolakshyapati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manish Kolakshyapati has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Kaoru Kurisu

    Director, Chugoku Rosai Hospital, 1-5-1 Hirotagaya, Kure, Hiroshima 737-0193, Japan

    21 shared publications
  • Kazuhiko Sugiyama

    Department of Clinical Oncology & Neuro-Oncology Program, Hiroshima University Hospital, Hiroshima 734-8551, Japan

    15 shared publications
  • Fumiyuki Yamasaki

    Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan

    14 shared publications
  • Takeshi Takayasu

    Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan

    11 shared publications
  • Vishwa Jeet Amatya

    Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan

    11 shared publications
  • Yukio Takeshima

    Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan

    10 shared publications

Latest Publications

  • Open Access

    Surgical Outcome and extent of resection in Endoscopic Endonasal Transphenoidal excision of Pituitary Tumor

    by Subodh Gautam, Manish Kolakshyapti, Saharoj Siddiqui, Ashmita Nepal

    Introduction: Pituitary adenomas are common benign tumors located intracranially that arises from the pituitary gland. Depending on their size and endocrine function of the tumor, they can be either asymptomatic or present with symptoms due to hormonal dysfunction or compression of nearby structures. Among the various surgical approaches that exist for the management of pituitary adenomas, the endoscopic endonasal transsphenoidal approach is a widely used technique. The study evaluates the surgical outcomes and extent of tumor resection using this approach. Materials and Methods: The study was conducted at Bir Hospital, Kathmandu, Nepal, which included 38 study participants with pituitary macroadenomas. A non-probability sampling method was used. Results: The most common presenting symptom was visual defects (57.8%), followed by headaches (31.5%) and galactorrhea (26.3%). Preoperative Knosp grading revealed 26.3% of cases as grade 0, 39.5% as grade 1, 21.1% as grade 2, and 13.2% as grade 3. Postoperatively, 78.9% of patients had complete tumor excision. Significant improvement in visual acuity was observed, with 21.1% achieving 6/9 vision in the right eye and 23.7% in the left eye. However, two patients showed no perception of light both pre- and post-operatively. The hormonal level decreased significantly post operatively. Conclusion: Pituitary adenomas often present late, leading to visual and endocrine impairment. The visual and endocrine improvement of the patient was significant following the Endoscopic endonasal transsphenoidal surgery, with most patients achieving complete tumor excision. Surgical outcomes at our center are comparable to existing data.

  • Detecting non-germinomatous germ cell tumor component by arterial spin labeling perfusion-weighted MR imaging in central nervous system germ cell tumor

    by Motoki Takano, Yasuyuki Kinoshita, Kazuhiko Sugiyama, Manish Kolakshyapati, Takeshi Takayasu, Ushio Yonezawa, Akira Taguchi, Yuji Akiyama, Vishwa Jeet Amatya, Yukio Takeshima, et al.


  • Advantage of high b value diffusion-weighted imaging for differentiation of common pediatric brain tumors in posterior fossa

    by Yusuke Takeishi, Takeshi Takayasu, Manish Kolakshyapati, Ushio Yonezawa, Vishwa Jeet Amatya, Motoki Takano, Akira Taguchi, Yukio Takeshima, Kazuhiko Sugiyama, Kaoru Kurisu, et al.


  • T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor

    by Shumpei Onishi, Vishwa Jeet Amatya, Manish Kolakshyapati, Motoki Takano, Ushio Yonezawa, Akira Taguchi, Yoko Kaichi, Yukio Takeshima, Kazuo Awai, Kazuhiko Sugiyama, et al.


  • Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature

    by Sayuru Tsuyuguchi, Kazuhiko Sugiyama, Yasuyuki Kinoshita, Manish Kolakshyapati, Takeshi Takayasu, Satoshi Usui, Motoki Takano, Ushio Yonezawa, Akira Taguchi, Vishwa Jeet Amatya, et al.


  • Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions

    by Manish Kolakshyapati, Akira Hashizume, Kazuhide Ochi, Hiroki Ueno, Yoko Kaichi, Takeshi Takayasu, Motoki Takano, Vega Karlowee, Yuji Akiyama, Kazuo Awai, et al.


  • Open Access

    Effect of bevacizumab against cystic components of brain tumors

    by Fumiyuki Yamasaki, Manish Kolakshyapati, Motoki Takano, Ushio Yonezawa, Ikuno Nishibuchi, Nobuki Imano, Akira Taguchi, Shumpei Onishi, Vishwa Jeet Amatya, Yukio Takeshima, et al.

    Background: Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented yet.Materials and Methods: Between 2008 and 2018, 139 patients with primary or metastatic brain tumors were treated with bevacizumab (BEV) in our institution. The images and symptoms before and after administration of BEV were examined, and changes in size of cysts were evaluated as follows: CR (complete disappearance), PR (reduction by ≥50%), MR (reduction by ≥25%), SD (size change P = .0055) and at best response timing (mean 76.3% vs 32.8%, P = .0050). Patients with cysts showed significant improvement in symptoms after the treatment with BEV compared to patients without cysts (P = .0033). However, response rate was not different between patients with or without cysts. Overall survival after starting BEV was not different between glioblastoma patients with or without cysts.Conclusion: Bevacizumab is effective against progressively increasing cysts. Although cysts reduction effect and tumor response and/or overall survival are independent, BEV may be effective in patients who are symptomatic due to cyst enlargement.


  • Open Access

    Updates on 2016 CNS tumor classification - Where do we stand?

    by Manish Kolakshyapati, Tejashwi Shrestha, Anish Man Singh, Rupendra Bahadur Adhikari, Prabin Shrestha

    The updated 2016 World Health Organization (WHO) classification of central nervous system (CNS) tumors has incorporated the molecular markers together with histological parameters in defining and diagnosing various tumor entities. This has led to major changes and revision of the classification. A number of new entities are classified based on clinical, diagnostic, and prognostic relevance and those without such relevance have been removed. Major changes are incorporated in diffuse glioma, medulloblastoma, pediatric gliomas, and other embryonal tumors. These new requisites make molecular testing a basic requirement for CNS tumor diagnosis and treatment. New treatment protocols are designed and targeted based on the genetic alteration involved in the tumor entity. The update aims to achieve accurate diagnosis, determine precise prognosis and ensure better patient treatment all through facilitating better categorization of clinical and experimental trials. The multidisciplinary team of clinicians treating such tumor patients in a developing country like Nepal should try to adopt this updated version of the classification so as to improve and upgrade the neuro-oncological services to meet the international standards.

  • Open Access

    Isolated Tuberculoma Mimicking Foramen Magnum Meningioma in the Absence of Primary Tuberculosis: A Case Report

    by Manish Kolakshyapati, Masaaki Takeda, Takafumi Mitsuhara, Satoshi Yamaguchi, Masaru Abiko, Shingo Matsuda, Kaoru Kurisu

    Central nervous system tuberculosis is a devastating complication of systemic tuberculosis. Intradural extramedullary (IDEM) tuberculoma at the foramen magnum is rare, and mimics en plaque meningioma. We report the case of a 53-year-old woman who presented with dysesthesia of the tongue and lower cranial nerve (CN) palsy, with onset 4 months prior to admission. The neurologic examination revealed left upper-limb weakness and hypoesthesia on the sole and dorsum of the left foot. Other physical examinations revealed no features of tubercular infection. Laboratory investigations likewise showed no signs of infection or inflammation. Magnetic resonance imaging of the brain showed an IDEM mass originating from the left intradural surface at the foramen magnum extending to the C2 segment and compressing the brainstem and upper cervical cord. The mass was isointense/hypointense on T1- and T2-weighted images and homogeneously-enhanced on postcontrast images. The lesion also exhibited the dural-tail sign and was preoperatively diagnosed as en plaque meningioma. The patient underwent surgery via the left transcondylar fossa approach with partial laminectomy of the atlas. Intraoperatively, the mass exhibited a dural origin and encased the vertebral artery and lower CNs, with strong adhesions. While the histopathological study of the mass was strongly suggestive of tuberculoma with multifocal granulomas, caseous necrosis, and Langerhans giant cells, extensive diagnostic studies failed to detect Mycobacterium tuberculosis itself. Although the patient had recurrence with multisystem involvement, she responded well to antitubercular treatment. IDEM tuberculoma of the foramen magnum may present as en plaque meningioma. Histopathology is required for a definitive diagnosis. Prompt surgical resection and decompression with adequate antitubercular treatment yield better neurological outcomes.


  • GERM-14. ADVANCED MR IMAGING OF GERMINOMA

    by Fumiyuki Yamasaki, Yasuyuki Kinoshita, Takeshi Takayasu, Satoshi Usui, Manish Kolakshyapati, Motoki Takano, Naoto Yamada, Kazuhiko Sugiyama, Kaoru Kurisu

    The differentiation of germinoma from other tumors can be very difficult. We evaluated the usefulness of advanced MRI for the differentiatial diagnosis of germinoma. MATERIALS AND Our IRB approved this retrospective study. We reviewed the images of 26 patients with histologically confirmed germinoma who were treated in our institution between 2003 and 2016. We also studied 25 patients with pineal tumors which included 14 non-germinomatous germ cell tumors (NGGCT), 9 pineal parenchymal tumors (PPT) and 2 meningioma. Patients underwent CT and conventional MRI and advanced MRI including diffusion-weighted imaging (DWI) and/or arterial spin labeling based perfusion-weighted imaging and single voxel proton MR spectroscopy (1HMRS). In germinoma patients group, age ranged from 9.1 to 37.7-years (average 17.5, median 14.6). 24 were male, and 2 were female patients. High lipids peak at 1HMRS was observed in 16 of 16 examined tumors. On the other hand, in the PPT and meningioma, lipid peaks were small or absent in 10 of 10 examined tumors. In NGGCT group, high lipids peak at 1HMRS was also observed in 11 of 12 examined tumors, while they did not show high intensity on DWI, rather, they showed low to high mixed intensity. ADC was statistically lower in germinoma group than in NGGCT group (P=0.0002). Relative tumor blood flow (rTBF) was statistically lower in germinoma group than in NGGCT group (P=0.0087). Lower ADC value, low rTBF and high lipids peak at 1HMRS are characteristics of germinoma.